Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT03018080
Title Pilot Study of Paclitaxel Plus Pembrolizumab in Metastatic HER2-Negative Breast Cancer (PePPy)
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Antoinette Tan, MD

Her2-receptor negative breast cancer


Paclitaxel + Pembrolizumab

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Levine Cancer Institute Charlotte North Carolina 28204 United States Details
*Shaded cells indicate that there was no data available from for the field